Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gloria Hsia"'
Autor:
Eric Sung, Jason ORourke, Raedun Clarke, Thomas H. Lee, Isabelle Riviere, Bi-Huei Yang, Rebecca Magdaleno, Gloria Hsia, Dell Farnan, Sjoukje J. C. van der Stegen, Stephanie Moreno, Chia-Wei Chang, Brigitte Senechal, Xu Yuan, Alma Gutierrez, Mark Plavsic, Meghan Eberhart, Bahram Valamehr, Abubakar Jalloh, Xiuyan Wang, Helena Shaked, Jerome Bressi, Yi-Shin Lai, Betsy Rezner, Devanjan S. Sikder, Ramzey Abujarour
Publikováno v:
Blood. 138:1766-1766
FT819 is a first-of-kind, allogeneic, off-the-shelf CAR T-cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line precisely engineered to insert a novel 1XX anti-CD19 chimeric antigen receptor (CAR) under the regulation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ec444808114702c4d19500c9a32016
https://doi.org/10.1182/blood-2021-152985
https://doi.org/10.1182/blood-2021-152985
Autor:
Bahram Valamehr, Samuel LaBarge, Yi-Shin Lai, Mochtar Pribadi, Suzanna Gasparian, Mandal Mili, Alma Gutierrez, Matthew Denholtz, Gloria Hsia, Jason ORourke, May Sumi, Bi-Huei Yang, Cokey Nguyen, Sandeep Kothapally Hanok, Alec Witty, Eric Sung, Amit R. Mehta, Raedun Clarke, Ramzey Abujarour, Eigen Peralta, Emily Carron, Thomas H. Lee, Emily Driver, Angela Gentile, Natalie Navarrete, David J. Robbins, Wen-I Yeh, Philip Chu, Chia-Wei Chang, Amanda D. Yzaguirre
Publikováno v:
Blood. 136:11-11
The development of chimeric antigen receptor (CAR) T cell therapeutics is widely recognized as a significant advancement for the treatment of cancer. However, several obstacles currently impede the broad use of CAR T cells, including the inherent pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d8f69cdaa6921660b3c4c80e2deffbb
https://doi.org/10.1182/blood-2020-138930
https://doi.org/10.1182/blood-2020-138930
Autor:
Ramzey Abujarour, Cheng-Jang Wu, Jason ORourke, Mandal Mili, Bahram Valamehr, Jolanta Stefanski, Gloria Hsia, Alec Witty, Bi-Huei Yang, Sjoukje J. C. van der Stegen, Gilberto Hernandez, Michel Sadelain, Mochtar Pribadi, Chia-Wei Chang, Helen Chu, Yi-Shin Lai, Raedun Clarke, Thomas H. Lee, Meilan Wu, Juan Zhen, Isabelle Riviere, Mushtaq Husain, Laurel Stokely, Chad Dufaud, Helena Shaked, Alma Gutierrez
Publikováno v:
Cancer Research. 80:3245-3245
Genetic engineering of T cells using a chimeric antigen receptor targeting CD19 antigen (CAR19) is now a well-established treatment of B cell malignancies. While cellular immunotherapies are entering front line treatment, substantial limitations curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b887f3dfdacd0fd61ab763cf4f11c2f
https://doi.org/10.1158/1538-7445.am2020-3245
https://doi.org/10.1158/1538-7445.am2020-3245
Autor:
Gloria Hsia
Publikováno v:
Microform & Imaging Review. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35a64331648b31470c5189bf498a115b
https://doi.org/10.1515/mfir.1977.6.1.11
https://doi.org/10.1515/mfir.1977.6.1.11